210 related articles for article (PubMed ID: 19660185)
1. Treatment with botulinum toxin improves the hyperexcitability of the facial motoneuron in patients with hemifacial spasm.
Ishikawa M; Takashima K; Kamochi H; Kusaka G; Shinoda S; Watanabe E
Neurol Res; 2010 Jul; 32(6):656-60. PubMed ID: 19660185
[TBL] [Abstract][Full Text] [Related]
2. Trigeminal afferent input alters the excitability of facial motoneurons in hemifacial spasm.
Ogawara K; Kuwabara S; Kamitsukasa I; Mizobuchi K; Misawa S; Hattori T
Neurology; 2004 May; 62(10):1749-52. PubMed ID: 15159472
[TBL] [Abstract][Full Text] [Related]
3. The effects of botulinum toxin A on ephaptic transmission in idiopathic hemifacial spasm.
Kurt T; Seçil Y; Gürgör N; Tokuçoğlu F; Beckmann Y; Ertekin C
Int J Neurosci; 2009; 119(11):2044-55. PubMed ID: 19863260
[TBL] [Abstract][Full Text] [Related]
4. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
Colakoglu BD; Cakmur R; Uzunel F
Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
[TBL] [Abstract][Full Text] [Related]
5. No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.
Lorenzano C; Bagnato S; Gilio F; Fabbrini G; Berardelli A
Neurotox Res; 2006 Apr; 9(2-3):141-4. PubMed ID: 16785111
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment status of hemifacial spasm in China.
Wang L; Hu X; Dong H; Wang W; Huang Y; Jin L; Luo Y; Zhang W; Lian Y; Liang Z; Shang H; Feng Y; Wu Y; Chen J; Luo W; Wan X
Chin Med J (Engl); 2014; 127(5):845-9. PubMed ID: 24571874
[TBL] [Abstract][Full Text] [Related]
7. Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.
Rudzińska M; Wójcik M; Szczudlik A
J Neural Transm (Vienna); 2010 Jun; 117(6):765-72. PubMed ID: 20467763
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
Frei K; Truong DD; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
[TBL] [Abstract][Full Text] [Related]
9. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
[TBL] [Abstract][Full Text] [Related]
10. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
11. Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study.
Butera C; Guerriero R; Amadio S; Ungaro D; Tesfaghebriel H; Bianchi F; Comi G; Del Carro U
Neurol Sci; 2013 Feb; 34(2):209-15. PubMed ID: 22367224
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience.
Barbosa ER; Takada LT; Gonçalves LR; Costa RM; Silveira-Moriyama L; Chien HF
Arq Neuropsiquiatr; 2010 Aug; 68(4):502-5. PubMed ID: 20730300
[TBL] [Abstract][Full Text] [Related]
15. Comparison of preseptal and pretarsal onabotulinum toxin an injection in patients with hemifacial spasm.
Yılmaz ATC; Yılmaz M; Öztekin MF
Int J Neurosci; 2021 Jun; 131(6):549-554. PubMed ID: 32233985
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological investigation of hemifacial spasm: F-waves of the facial muscles.
Ishikawa M; Ohira T; Namiki J; Gotoh K; Takase M; Toya S
Acta Neurochir (Wien); 1996; 138(1):24-32. PubMed ID: 8686521
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A improves psychological distress in patients with hemifacial spasm.
Wang C; Zhu X; Xia L; Xie P; Tian X; Shang J; Han Q
Acta Neurol Belg; 2022 Feb; 122(1):43-49. PubMed ID: 33515182
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.
Defazio G; Abbruzzese G; Girlanda P; Vacca L; Currà A; De Salvia R; Marchese R; Raineri R; Roselli F; Livrea P; Berardelli A
Arch Neurol; 2002 Mar; 59(3):418-20. PubMed ID: 11890846
[TBL] [Abstract][Full Text] [Related]
19. The influence of botulinum toxin on auditory disturbances in hemifacial spasm.
Rudzińska M; Wójcik M; Zajdel K; Hydzik-Sobocińska K; Malec M; Hartel M; Składzień J; Szczudlik A
Neurol Neurochir Pol; 2012; 46(1):29-36. PubMed ID: 22426760
[TBL] [Abstract][Full Text] [Related]
20. Experimental study on the correlation between abnormal muscle responses and F waves in hemifacial spasm.
Hai J; Pan QG
Neurol Res; 2007 Sep; 29(6):553-6. PubMed ID: 17948344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
